Loading clinical trials...
Loading clinical trials...
Objective: This study is designed to determine whether growth hormone treatment in children 8 to 18 years of age alters function of the lining of the arteries. This may play a role in increasing or de...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ohio State University
Collaborators
NCT00001595 · Panhypopituitarism, Gigantism/Acromegaly, and more
NCT06382155 · Idiopathic Short Stature
NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more
NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency
NCT05775523 · Growth Hormone Deficiency
Ohio State University
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions